Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
2.640
+0.140 (5.60%)
At close: Apr 2, 2025, 4:00 PM
2.400
-0.240 (-9.09%)
After-hours: Apr 2, 2025, 7:56 PM EDT

Ensysce Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Net Income
-7.99-10.61-24.17-29.080.06
Upgrade
Depreciation & Amortization
---00
Upgrade
Other Amortization
1.20.330.951.92-
Upgrade
Loss (Gain) From Sale of Assets
---0--
Upgrade
Stock-Based Compensation
0.110.881.070.120.18
Upgrade
Other Operating Activities
0.03-0.43-1.2120.1-1.67
Upgrade
Change in Accounts Receivable
-0.030.180.16-0.440.17
Upgrade
Change in Accounts Payable
-0.58-1.232.64-1.421.18
Upgrade
Change in Other Net Operating Assets
-0.250.112.670.56-1.17
Upgrade
Operating Cash Flow
-7.5-10.78-17.89-8.24-1.25
Upgrade
Sale of Property, Plant & Equipment
--0--
Upgrade
Investing Cash Flow
--0--
Upgrade
Long-Term Debt Issued
-1.617.5314.381.1
Upgrade
Total Debt Issued
-1.617.5314.381.1
Upgrade
Long-Term Debt Repaid
-0.86-1.45-2-0.96-
Upgrade
Net Debt Issued (Repaid)
-0.860.155.5313.421.1
Upgrade
Issuance of Common Stock
4.19.053.786.89-
Upgrade
Other Financing Activities
6.64-0.45-0.55-0
Upgrade
Financing Cash Flow
9.888.768.7720.311.1
Upgrade
Net Cash Flow
2.38-2.02-9.1212.07-0.15
Upgrade
Cash Income Tax Paid
00000
Upgrade
Levered Free Cash Flow
-4.96-7.42-11.19-14.66-3.27
Upgrade
Unlevered Free Cash Flow
-5.35-7.53-11.36-14.57-2.65
Upgrade
Change in Net Working Capital
1.251.71-2.712.281.82
Upgrade
Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q